Enhancement of chemotherapeutic drug-induced apoptosis by a cyclooxygenase-2 inhibitor in hypopharyngeal carcinoma cells

Cancer Letters

Volumn 201, Issue 2, 2003, Pages 157-163

  Peng, Jyh Ping ^a   Liu, Li Teh ^b   Chang, Hui Chiu ^b   Hung, Wen Chun ^b  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Apoptosis; Chemotherapeutic drug; Cyclin dependent kinase; Cyclooxygenase 2; Hypopharyngeal carcinoma

Indexed keywords

CASPASE; CISPLATIN; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN G1; CYCLINE; CYCLOOXYGENASE 2 INHIBITOR; CYCLOPHOSPHAMIDE; DNA FRAGMENT; ETOPOSIDE; FLUOROURACIL; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CARCINOMA CELL; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; ENZYME ACTIVATION; HUMAN; HUMAN CELL; HYPOPHARYNX CARCINOMA; MITOSIS INHIBITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

EID: 0242352526     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(03)00470-1     Document Type: Article

References (24)

1. Ho C.M., Lam K.H., Wei W.I., Yuan P.W., Lam L.K. Squamous cell carcinoma of the hypopharynx-analysis of treatment results. Head Neck. 15:1993;405-412.
2. HO C.M., Lam K.H., Wei W.I., Lam L.K., Yuan P.W. Recurrence of laryngeal or hypopharyngeal primary tumor after radical neck dissection for postradiotherapy nodal metastasis. Head Neck. 16:1994;555-558.
3. Jung T.T.K., Berlinger N.T., Juhn S.K. Prostaglandins in squamous cell carcinoma of the head and neck: a preliminary study. Laryngoscope. 95:1985;307-312.
4. Smith W.L., Garavito M., DeWitt D.L. Prostaglandin endoperoxide H synthases (cyclooxygenase)-1 and -2. J. Biol. Chem. 271:1996;33157-33160.
5. Goetzl E., An J.S., Smith W.L. Specificity of expression and effects of eicosanoid mediators in normal physiology and human diseases. FASEB J. 9:1995;1051-1058.
6. DuBois R.N., Abramson S.B., Crofford L., Gupta R.A., Simon S.L., Van De Putte L.B., Lipsky L.P. Cyclooxygenases in biology and disease. FASEB J. 12:1998;1063-1073.
7. Ristiaki A., Honkanen N., Jankala H., Sipponen P., Harkonen M. Expression of cyclooxygenase-2 in human gastric carcinoma. Cancer Res. 57:1997;1276-1280.
8. Wilson K.T., Fu S., Ramanujam K.S., Meltzer S.J. Increased expression of inducible nitric oxide and COX-2 in Barrett's esophagus and associated adenocarcinoma. Cancer Res. 58:1998;2929-2934.
9. Hida T., Yatabe Y., Achiwa H., Muramatsu H., Kozaki K., Nakamura S., Ogawa M., Mitsudomi T., Sugiura T., Takahashi T. Increased expression of cyclooxygenase-2 occurs frequently in human lung cancers, specifically in adenocarcinoma. Cancer Res. 58:1998;3761-3764.
10. Tsujii M., DuBois R.N. Alterations in cell adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell. 83:1995;493-501.
11. Tsujii M., Kawano S., DuBois R.N. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc. Natl. Acad. Sci. USA. 94:1997;3336-3340.
12. 2. Adv. Exp. Med. Biol. 407:1997;163-170.
13. Peng J.P., Su C.Y., Chang H.C., Chai C.Y., Hung W.C. Over-expression of cyclooxygenase-2 in squamous cell carcinoma of the hypopharynx. Human Pathol. 33:2002;100-104.
14. KIP1 expression in estrogen receptor-negative lung cancer cells. Oncogene. 18:1999;4269-4274.
15. Hung W.C., Chang H.C., Chuang L.Y. Activation of caspase-3-like proteases in apoptosis induced by sphingosine and other long-chain bases in Hep3B hepatoma cells. Biochem. J. 338:1999;161-166.
16. Niedner H., Christen R., Lin X., Kondo A., Howell S.B. Identification of genes that mediate sensitivity to cisplatin. Mol. Pharmacol. 60:2001;1153-1160.
17. Muscar J.E., Stellman S.D., Wynder F.L. Non-steroidal anti-inflammatory drugs and colorectal cancer. Cancer. 74:1994;1847-1854.
18. Schreinemachers D.M., Everson R.B. Aspirin use and lung, colon, and breast cancer incidence in a prospective study. Epidemiology. 5:1994;138-146.
19. Harris R.E., Nambookiri K.K., Farrar W.B. Non-steroidal anti-inflammatory drugs and breast cancer. Epidemiology. 7:1996;203-205.
20. Johansen L.V., Grau C., Overgaard J. Hypopharyngeal squamous cell carcinoma-treatment results in 138 consecutively admitted patients. Acta Oncol. 39:2000;529-536.
21. Forastere A.A. Induction and adjuvant chemotherapy for head and neck cancer: future perspectives. Acta Otorhinolaryngol. Belg. 53:1999;277-280.
22. Kim M.S., Ki S.L., Bertolami C.N., Cherrick H.M., Park N.H. State of p53, Rb and DCC tumor suppressor genes in human oral cancer cell lines. Anticancer Res. 13:1993;1405-1413.
23. Patel V.A., Dunn M.J., Sorokin A. Regulation of MDR-1 (p-glycoprotein) by cyclooxygenase-2. J. Biol. Chem. 277:2002;38915-38920.
24. Hida T., Kozaki K., Muramatsu H., Masuda A., Shimizu S., Mitsudomi T., Sugiura T., Ogawa M., Takahashi T. Cyclooxygenase-2 inhibitor induces apoptosis and enhances cytoxicity of various anticancer agents in non-small cell lung cancer cell lines. Clin. Cancer Res. 6:2000;2006-2011.